Anticancer agent 110
Anticancer agent 110 is an anticancer agent with in vitro anticancer activity and excellent anti-leukemia potency. Anticancer agent 110 is highly cytotoxic to K-562 lineage chronic myelogenous leukemia cells at nanomolar concentrations. Anticancer agent 110 causes DNA damage and leads to apoptosis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 887349-03-3
- 分子式: C18H13FN6OS
- 分子量:380.40
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CAKI-1 | IC50 |
772 nM
Compound: 3d
|
Inhibition of cell growth in human CAKI-1 cells incubated for 48 hrs by SRB assay
Inhibition of cell growth in human CAKI-1 cells incubated for 48 hrs by SRB assay
|
[PMID: 36809707] |
| HaCaT | IC50 |
>100 μM
Compound: 3d
|
Antiproliferative activity against human HaCaT cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HaCaT cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 36809707] |
| HCT-15 | IC50 |
347 nM
Compound: 3d
|
Inhibition of cell growth in human HCT-15 cells incubated for 48 hrs by SRB assay
Inhibition of cell growth in human HCT-15 cells incubated for 48 hrs by SRB assay
|
[PMID: 36809707] |
| J774.2 | IC50 |
70.67 μM
Compound: 3d
|
Antiproliferative activity against J774.2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against J774.2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 36809707] |
| K562 | IC50 |
0.7 μM
Compound: 3d
|
Antiproliferative activity against human K562 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 36809707] |
| K562 | IC50 |
56.4 nM
Compound: 3d
|
Inhibition of cell growth in human K562 cells incubated for 48 hrs by SRB assay
Inhibition of cell growth in human K562 cells incubated for 48 hrs by SRB assay
|
[PMID: 36809707] |
| KM12 | IC50 |
927 nM
Compound: 3d
|
Inhibition of cell growth in human KM12 cells incubated for 48 hrs by SRB assay
Inhibition of cell growth in human KM12 cells incubated for 48 hrs by SRB assay
|
[PMID: 36809707] |
| LOX IMVI | IC50 |
206 nM
Compound: 3d
|
Inhibition of cell growth in human LOX IMVI cells incubated for 48 hrs by SRB assay
Inhibition of cell growth in human LOX IMVI cells incubated for 48 hrs by SRB assay
|
[PMID: 36809707] |
| M14 | IC50 |
261 nM
Compound: 3d
|
Inhibition of cell growth in human M14 cells incubated for 48 hrs by SRB assay
Inhibition of cell growth in human M14 cells incubated for 48 hrs by SRB assay
|
[PMID: 36809707] |
| NCI-H460 | IC50 |
993 nM
Compound: 3d
|
Inhibition of cell growth in human NCI-H460 cells incubated for 48 hrs by SRB assay
Inhibition of cell growth in human NCI-H460 cells incubated for 48 hrs by SRB assay
|
[PMID: 36809707] |
| NIH3T3 | IC50 |
>100 μM
Compound: 3d
|
Antiproliferative activity against NIH3T3 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against NIH3T3 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 36809707] |
| SW-620 | IC50 |
118 nM
Compound: 3d
|
Inhibition of cell growth in human SW-620 cells incubated for 48 hrs by SRB assay
Inhibition of cell growth in human SW-620 cells incubated for 48 hrs by SRB assay
|
[PMID: 36809707] |
| T47D | IC50 |
896 nM
Compound: 3d
|
Inhibition of cell growth in human T47D cells incubated for 48 hrs by SRB assay
Inhibition of cell growth in human T47D cells incubated for 48 hrs by SRB assay
|
[PMID: 36809707] |
| UACC-62 | IC50 |
56.9 nM
Compound: 3d
|
Inhibition of cell growth in human UACC-62 cells incubated for 48 hrs by SRB assay
Inhibition of cell growth in human UACC-62 cells incubated for 48 hrs by SRB assay
|
[PMID: 36809707] |
体外実験
Anticancer agent 110 (compound 3d) (0.01 μM-100 μM) inhibits leukemia K-562 cells with IC50 of 0.7 μM[1].
Anticancer agent 110 (70 nM, 700 nM; 24 h) causes a higher level of DNA damage in K-562 cells[1].
Anticancer agent 110 (70 nM, 700 nM; 24 h) induces pro-apoptotic changes in the morphology of leukemia cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
化学情報
-
CAS 番号 887349-03-3
-
分子量 380.40
-
分子式 C18H13FN6OS
-
SMILES
O=C(C1=CC=C(N2N=NN=C2)C=C1)NC3=NC=C(CC4=CC=C(C=C4)F)S3
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)